Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis

Purpose. This study aimed to develop and analyse poly(DL-lactic acid)-methacrylic acid nanospheres bound to the chelating ligand diethylenetriaminepentaacetic acid (DTPA)  for the targeted delivery of amantadine in Amyotrophic Lateral Sclerosis (ALS). Methods. The nanospheres were prepared by a doub...

Full description

Bibliographic Details
Published in:Journal of Pharmacy & Pharmaceutical Sciences
Main Authors: Zamanzima Mazibuko, Sunaina Indermun, Mershen Govender, Pradeep Kumar, Lisa C du Toit, Yahya E Choonara, Girish Modi, Dinesh Naidoo, Viness Pillay
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Online Access:https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/29595
_version_ 1850087001338937344
author Zamanzima Mazibuko
Sunaina Indermun
Mershen Govender
Pradeep Kumar
Lisa C du Toit
Yahya E Choonara
Girish Modi
Dinesh Naidoo
Viness Pillay
author_facet Zamanzima Mazibuko
Sunaina Indermun
Mershen Govender
Pradeep Kumar
Lisa C du Toit
Yahya E Choonara
Girish Modi
Dinesh Naidoo
Viness Pillay
author_sort Zamanzima Mazibuko
collection DOAJ
container_title Journal of Pharmacy & Pharmaceutical Sciences
description Purpose. This study aimed to develop and analyse poly(DL-lactic acid)-methacrylic acid nanospheres bound to the chelating ligand diethylenetriaminepentaacetic acid (DTPA)  for the targeted delivery of amantadine in Amyotrophic Lateral Sclerosis (ALS). Methods. The nanospheres were prepared by a double emulsion solvent evaporation technique statistically optimized employing a 3-Factor Box-Behnken experimental design. Analysis of the particle size, zeta potential, polydispersity (Pdl), morphology, drug entrapment and drug release kinetics were carried out. Results. The prepared nanospheres were determined to have particle sizes ranging from 68.31 to 113.6 nm (Pdl ≤ 0.5). An initial burst release (50% of amantadine released in 24 hr) was also obtained, followed by a prolonged release phase of amantadine over 72 hr. Successful conjugation of the chelating ligand onto the surface of the optimised nanospheres was thereafter achieved and confirmed by TEM. The synthesized modified nanospheres were spherical in shape, 105.6 nm in size, with a PdI of 0.24 and zeta potential of -28.0 mV. Conjugation efficiency was determined to be 74%. In vitro and ex vivo cell study results confirmed the intracellular uptake of the modified nanospheres by the NSC-34 cell line and the non-cytotoxicity of the synthesized nanospheres. Conclusions. Biocompatible amantadine-loaded nanospheres were successfully designed, characterized and optimized employing the randomized Box-Behnken statistical design. Delivery of amantadine over 72 hrs was achieved, with the nanospheres being of a size capable of internalization by the NSC- 34 cells.   This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.
format Article
id doaj-art-e007ebbfbdda4b94adf14fece3e3536e
institution Directory of Open Access Journals
issn 1482-1826
language English
publishDate 2018-03-01
publisher Frontiers Media S.A.
record_format Article
spelling doaj-art-e007ebbfbdda4b94adf14fece3e3536e2025-08-20T00:10:28ZengFrontiers Media S.A.Journal of Pharmacy & Pharmaceutical Sciences1482-18262018-03-012110.18433/jpps29595Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral SclerosisZamanzima Mazibuko0Sunaina Indermun1Mershen Govender2Pradeep Kumar3Lisa C du Toit4Yahya E Choonara5Girish Modi6Dinesh Naidoo7Viness Pillay8Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.Department of Neurology, Division of Neurosciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.Department of Neurosurgery, Division of Neurosciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.Purpose. This study aimed to develop and analyse poly(DL-lactic acid)-methacrylic acid nanospheres bound to the chelating ligand diethylenetriaminepentaacetic acid (DTPA)  for the targeted delivery of amantadine in Amyotrophic Lateral Sclerosis (ALS). Methods. The nanospheres were prepared by a double emulsion solvent evaporation technique statistically optimized employing a 3-Factor Box-Behnken experimental design. Analysis of the particle size, zeta potential, polydispersity (Pdl), morphology, drug entrapment and drug release kinetics were carried out. Results. The prepared nanospheres were determined to have particle sizes ranging from 68.31 to 113.6 nm (Pdl ≤ 0.5). An initial burst release (50% of amantadine released in 24 hr) was also obtained, followed by a prolonged release phase of amantadine over 72 hr. Successful conjugation of the chelating ligand onto the surface of the optimised nanospheres was thereafter achieved and confirmed by TEM. The synthesized modified nanospheres were spherical in shape, 105.6 nm in size, with a PdI of 0.24 and zeta potential of -28.0 mV. Conjugation efficiency was determined to be 74%. In vitro and ex vivo cell study results confirmed the intracellular uptake of the modified nanospheres by the NSC-34 cell line and the non-cytotoxicity of the synthesized nanospheres. Conclusions. Biocompatible amantadine-loaded nanospheres were successfully designed, characterized and optimized employing the randomized Box-Behnken statistical design. Delivery of amantadine over 72 hrs was achieved, with the nanospheres being of a size capable of internalization by the NSC- 34 cells.   This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/29595
spellingShingle Zamanzima Mazibuko
Sunaina Indermun
Mershen Govender
Pradeep Kumar
Lisa C du Toit
Yahya E Choonara
Girish Modi
Dinesh Naidoo
Viness Pillay
Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis
title Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis
title_full Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis
title_fullStr Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis
title_full_unstemmed Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis
title_short Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis
title_sort targeted delivery of amantadine loaded methacrylate nanosphere ligands for the potential treatment of amyotrophic lateral sclerosis
url https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/29595
work_keys_str_mv AT zamanzimamazibuko targeteddeliveryofamantadineloadedmethacrylatenanosphereligandsforthepotentialtreatmentofamyotrophiclateralsclerosis
AT sunainaindermun targeteddeliveryofamantadineloadedmethacrylatenanosphereligandsforthepotentialtreatmentofamyotrophiclateralsclerosis
AT mershengovender targeteddeliveryofamantadineloadedmethacrylatenanosphereligandsforthepotentialtreatmentofamyotrophiclateralsclerosis
AT pradeepkumar targeteddeliveryofamantadineloadedmethacrylatenanosphereligandsforthepotentialtreatmentofamyotrophiclateralsclerosis
AT lisacdutoit targeteddeliveryofamantadineloadedmethacrylatenanosphereligandsforthepotentialtreatmentofamyotrophiclateralsclerosis
AT yahyaechoonara targeteddeliveryofamantadineloadedmethacrylatenanosphereligandsforthepotentialtreatmentofamyotrophiclateralsclerosis
AT girishmodi targeteddeliveryofamantadineloadedmethacrylatenanosphereligandsforthepotentialtreatmentofamyotrophiclateralsclerosis
AT dineshnaidoo targeteddeliveryofamantadineloadedmethacrylatenanosphereligandsforthepotentialtreatmentofamyotrophiclateralsclerosis
AT vinesspillay targeteddeliveryofamantadineloadedmethacrylatenanosphereligandsforthepotentialtreatmentofamyotrophiclateralsclerosis